{"transactions":[{"id":2205229,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-19T16:05:42.000Z","date":"2022-06-24","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units vested on June 24, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Stock Units vested on June 24, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-22-019823","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000149315222019823/ownership.xml","form_type":"4"}},{"id":2205228,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-07-19T16:05:42.000Z","date":"2022-06-24","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120863,"source":{"system":"sec-edgar","filing":"0001493152-22-019823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000149315222019823/ownership.xml","form_type":"4"}},{"id":2330579,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-03-16T21:08:51.000Z","date":"2022-03-16","kind":"purchase","acquired":true,"shares":40000,"price":1.189,"value":47560.0,"ownership":{"direct":true},"balance_after":110863,"source":{"system":"sec-edgar","filing":"0001493152-22-007054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000149315222007054/ownership.xml","form_type":"4"}},{"id":2653299,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-28T20:36:04.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":10000,"derivative":{"exercise_price":0,"exercise_date":"2022-06-24","expiration_date":"2022-06-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-21-015451","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000149315221015451/ownership.xml","form_type":"4"}},{"id":2653298,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-06-28T20:36:04.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":5.46,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-21-015451","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000149315221015451/ownership.xml","form_type":"4"}},{"id":2944264,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T06:17:38.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":18416,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share."}],"balance_after":70863,"source":{"system":"sec-edgar","filing":"0001493152-20-023588","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000149315220023588/ownership.xml","form_type":"4"}},{"id":3104192,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-06-19T17:37:16.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":62000,"derivative":{"exercise_price":2.38,"underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001493152-20-011545","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000149315220011545/ownership.xml","form_type":"4"}},{"id":3458486,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-07-19T21:38:54.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":50000,"derivative":{"exercise_price":2.12,"expiration_date":"2029-07-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-042849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000120919119042849/doc4.xml","form_type":"4"}},{"id":3827179,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-09-04T21:37:33.000Z","date":"2018-08-30","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":50000,"derivative":{"exercise_price":2.4,"expiration_date":"2028-08-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-18-049410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000120919118049410/doc4.xml","form_type":"4"}},{"id":3857757,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock purchase warrants","published_at":"2018-07-31T21:39:11.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":52447,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":52447,"derivative":{"exercise_price":3,"exercise_date":"2019-02-01","expiration_date":"2024-02-01","underlying":"Common stock","underlying_shares":52447},"source":{"system":"sec-edgar","filing":"0001493152-18-010763","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000149315218010763/ownership.xml","form_type":"4"}},{"id":3857756,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, no par value","published_at":"2018-07-31T21:39:11.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":52447,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":52447,"source":{"system":"sec-edgar","filing":"0001493152-18-010763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000149315218010763/ownership.xml","form_type":"4"}},{"id":3877047,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Shares","published_at":"2018-07-03T22:26:32.000Z","date":"2018-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will become exercisable on June 30, 2019, based upon continued service on the board of directors."}],"balance_after":40000,"derivative":{"exercise_price":2.06,"expiration_date":"2023-06-30","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-041306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118041306/doc4.xml","form_type":"4"}},{"id":4277355,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-19T21:26:48.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018, and one day before the Company's next annual meeting of shareholders, based upon continued service on the board of directors from the date of grant on June 15, 2017."}],"balance_after":20000,"derivative":{"exercise_price":5.1,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-040982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000120919117040982/doc4.xml","form_type":"4"}},{"id":4277354,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-19T21:26:48.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":6520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options are granted to directors annually. These options are a \"transitional grant\" reflecting the change in the date of the annual grant from February to the date of the annual meeting of shareholders. The options are 32.60% of the annual grant for the 119-day gap between February 16, 2017, one year from the last annual grant, and June 15, 2017, date of the full annual grant for 2017-2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018, and one day before the Company's next annual meeting of shareholders, based upon continued service on the board of directors from the date of grant on June 15, 2017."}],"balance_after":6520,"derivative":{"exercise_price":5.1,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":6520},"source":{"system":"sec-edgar","filing":"0001209191-17-040982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420120/000120919117040982/doc4.xml","form_type":"4"}},{"id":490835,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Phantom Stock Units SSP","published_at":"2012-06-01T21:35:39.000Z","date":"2012-05-31","kind":"grant","acquired":true,"shares":60,"price":21.87,"value":1312.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":1211,"derivative":{"underlying":"Common Stock","underlying_shares":60},"source":{"system":"sec-edgar","filing":"0001225208-12-013547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520812013547/doc4.xml","form_type":"4"}},{"id":491189,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Phantom Stock Units SSP","published_at":"2012-05-16T19:32:48.000Z","date":"2012-05-15","kind":"grant","acquired":true,"shares":69,"price":22.3,"value":1538.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":1151,"derivative":{"underlying":"Common Stock","underlying_shares":69},"source":{"system":"sec-edgar","filing":"0001225208-12-012559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520812012559/doc4.xml","form_type":"4"}},{"id":492114,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Phantom Stock Units SSP","published_at":"2012-05-01T20:59:30.000Z","date":"2012-04-30","kind":"grant","acquired":true,"shares":15,"price":22.9,"value":343.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":1082,"derivative":{"underlying":"Common Stock","underlying_shares":15},"source":{"system":"sec-edgar","filing":"0001225208-12-010669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520812010669/doc4.xml","form_type":"4"}},{"id":495170,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Stock Appreciation Rights","published_at":"2012-02-27T23:04:01.000Z","date":"2012-02-23","kind":"grant","acquired":true,"shares":92593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":92593,"derivative":{"exercise_price":21.03,"exercise_date":"2019-02-23","expiration_date":"2019-02-23","underlying":"Common Stock","underlying_shares":92593},"source":{"system":"sec-edgar","filing":"0001225208-12-005638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520812005638/doc4.xml","form_type":"4"}},{"id":495169,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Stock Appreciation Rights","published_at":"2012-02-27T23:04:01.000Z","date":"2012-02-23","kind":"grant","acquired":true,"shares":109223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":109223,"derivative":{"exercise_price":21.03,"exercise_date":"2017-02-23","expiration_date":"2017-02-23","underlying":"Common Stock","underlying_shares":109223},"source":{"system":"sec-edgar","filing":"0001225208-12-005638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520812005638/doc4.xml","form_type":"4"}},{"id":495168,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2012-02-27T23:04:01.000Z","date":"2012-02-23","kind":"grant","acquired":true,"shares":21206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements."}],"balance_after":151138,"source":{"system":"sec-edgar","filing":"0001225208-12-005638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520812005638/doc4.xml","form_type":"4"}},{"id":507575,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Stock Appreciation Rights","published_at":"2011-03-01T00:07:38.000Z","date":"2011-02-24","kind":"grant","acquired":true,"shares":91876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":91876,"derivative":{"exercise_price":18.9,"exercise_date":"2018-02-24","expiration_date":"2018-02-24","underlying":"Common Stock","underlying_shares":91876},"source":{"system":"sec-edgar","filing":"0001225208-11-007689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520811007689/doc4.xml","form_type":"4"}},{"id":507574,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Stock Appreciation Rights","published_at":"2011-03-01T00:07:38.000Z","date":"2011-02-24","kind":"grant","acquired":true,"shares":110981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":110981,"derivative":{"exercise_price":18.9,"exercise_date":"2016-02-24","expiration_date":"2016-02-24","underlying":"Common Stock","underlying_shares":110981},"source":{"system":"sec-edgar","filing":"0001225208-11-007689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520811007689/doc4.xml","form_type":"4"}},{"id":507573,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2011-03-01T00:07:38.000Z","date":"2011-02-24","kind":"grant","acquired":true,"shares":37851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements."}],"balance_after":125263,"source":{"system":"sec-edgar","filing":"0001225208-11-007689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520811007689/doc4.xml","form_type":"4"}},{"id":522141,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Senior Vice President"}}],"security":"Stock Appreciation Rights","published_at":"2010-03-02T02:01:40.000Z","date":"2010-02-25","kind":"grant","acquired":true,"shares":90090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":90090,"derivative":{"exercise_price":17.69,"exercise_date":"2015-02-25","expiration_date":"2015-02-25","underlying":"Common Stock","underlying_shares":90090},"source":{"system":"sec-edgar","filing":"0001225208-10-006401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520810006401/doc4.xml","form_type":"4"}},{"id":522140,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2010-03-02T02:01:40.000Z","date":"2010-02-25","kind":"grant","acquired":true,"shares":22284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements."}],"balance_after":84350,"source":{"system":"sec-edgar","filing":"0001225208-10-006401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520810006401/doc4.xml","form_type":"4"}},{"id":527164,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2009-11-03T22:22:09.000Z","date":"2009-10-30","kind":"grant","acquired":true,"shares":17616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that  Mr. Redmond remains in the continuous employ of Pfizer until that anniversary date. This grant represents a portion of Mr. Redmond's Executive Long-Term Incentive Program Award for 2010."}],"balance_after":61148,"source":{"system":"sec-edgar","filing":"0001225208-09-021562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520809021562/doc4.xml","form_type":"4"}},{"id":527163,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16753,"kind":"person","name":"Redmond Cavan M.","position":1,"cik":"0001420120","reported_name":"Redmond Cavan M.","relationship":{"officer":true,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2009-11-03T22:22:09.000Z","date":"2009-10-30","kind":"grant","acquired":true,"shares":29360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that Mr. Redmond remains in the continuous employ of Pfizer until that anniversary date. This grant was made in connection with Mr. Redmond's election as Pfizer's Senior Vice President; Group President - Diversified Businesses effective October 16, 2009."}],"balance_after":43532,"source":{"system":"sec-edgar","filing":"0001225208-09-021562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520809021562/doc4.xml","form_type":"4"}}]}